Join our Community
Support ToI and remove all ads
Learn more
×

Albert Bourla

Pfizer CEO Albert Bourla speaks, ahead of the G-7 summit in St. Ives, England, June 10, 2021. (Patrick Semansky/AP)
August 15, 2022, 7:57 pm
Pfizer CEO Bourla tests positive for COVID, has ‘very mild symptoms’
Coronavirus vaccine pioneer confident he will make a speedy recovery after taking his firm’s virus treatment drug, says he’s ‘thankful’ to be quadruple-vaccinated
By ToI Staff
Dr Albert Bourla (right) receives the 2022 Genesis Prize from Israel's President Isaac Herzog, left, and Stan Polovets, co-founder and chairman/CEO of the Genesis Prize Foundation. (Amos Ben-Gershom/GPO)
June 30, 2022, 12:35 am
Pfizer boss Bourla receives $1M. Genesis Prize, pledges funds for Holocaust museum
Protesting anti-vaxxers greet hundreds of guests at star-studded Jerusalem event; Bourla, son of Greek survivors, to give cash to planned Holocaust Museum in Thessaloniki
By Sue Surkes
Albert Bourla, Chief Executive Officer, Pfizer, speaks at a Press Conference on Pfizer and Partners Announce Accord for a Healthier World at the 51st annual meeting of the World Economic Forum, WEF, in Davos, Switzerland, May 25, 2022. (Gian Ehrenzeller/Keystone via AP)
June 27, 2022, 4:18 pm
Pfizer CEO to Israeli TV: Omicron shots ready for use as soon as FDA approves
Albert Bourla insists his company’s original vaccine is safe for children as young as 6 months, says he’s aiming to create vaccine that offers yearlong protection
By ToI Staff
Pfizer CEO Albert Bourla speaks during a ceremony in Thessaloniki, Greece, on Oct. 12, 2021. (AP Photo/Giannis Papanikos, File)
February 9, 2022, 3:47 am
Pfizer sees COVID-19 vaccine, therapeutic sales topping $50 billion in 2022
Chief Executive Albert Bourla says 2021 was a ‘watershed year’ for drugmaker; its efforts during the pandemic ‘fundamentally changed our company forever’
By John BIERS
Pfizer CEO Albert Bourla attends a ceremony in the northern city of Thessaloniki, Greece, October 12, 2021. (AP Photo/Giannis Papanikos, file)
January 22, 2022, 10:01 pm
Pfizer CEO to Israeli TV: World should be back to near-normal in ‘a few months’
Albert Bourla says US-based pharma firm is aiming to produce annual shot to cover all COVID variants; accuses anti-vaxxers of causing millions of deaths by spreading misinformation
By ToI Staff
Director of the Institute of Biological Research, Prof. Shmuel Shapira, at the laboratory in Ness Ziona on August 6, 2020. (Ariel Hermoni/ Defense Ministry)
January 19, 2022, 2:48 pm
Ex-head developer of Israeli COVID vaccine slams Genesis Prize for Pfizer CEO
Prof. Shmuel Shapira, former head of the Defense Ministry’s Biological Institute, calls pharma giant’s vaccines ‘mediocre,’ says company only wanted to ‘rake in billions’
By ToI Staff
Pfizer CEO Albert Bourla speaks during a ceremony in Thessaloniki, Greece, on Oct. 12, 2021. (Giannis Papanikos/AP)
January 19, 2022, 9:06 am
Pfizer CEO Albert Bourla awarded $1 million Genesis Prize for 2022
Foundation cites Jewish executive’s leadership, willingness to take risks in order to produce vaccine as quickly as possible; will donate money to Holocaust education
By ToI Staff
Pfizer CEO Albert Bourla speaks during a ceremony in Thessaloniki, Greece, on October 12, 2021. (AP Photo/Giannis Papanikos, File)
January 17, 2022, 12:24 pm
Pfizer CEO: Virus will be here for years but this may be last wave with restrictions
Bourla says boosters against coronavirus will remain necessary, but anti-COVID pill ‘changes everything’
By ToI Staff
A man receives a fourth Pfizer-BioNTech COVID-19 vaccine from a Magen David Adom national emergency service volunteer, at a private nursing home, in Netanya, Israel, on Wednesday, January 5, 2022. (AP/Ariel Schalit)
January 10, 2022, 8:44 pm
Pfizer CEO questions whether 4th dose of COVID vaccine needed
‘That’s something that needs to be tested,’ Albert Bourla says as Israel gives extra boosters to at-risk groups; adds that inoculation adapted to Omicron will be ready in March
By ToI Staff
Image provided by Pfizer in October 2021 shows the company's COVID-19 Paxlovid pills. (Pfizer via AP)
December 26, 2021, 7:54 pm
Health Ministry grants emergency approval to Pfizer’s anti-COVID pill
Ministry says first shipment of Paxlovid oral medication slated to arrive in Israel in coming days, is expected to be equally effective against Omicron
By ToI Staff and Agencies
File: Pfizer's experimental COVID-19 pills, which the drugmaker said on November 16, 2021 that it is submitting for US authorization, setting the stage for a likely launch in coming weeks. (Pfizer via AP)
December 25, 2021, 11:00 pm
Israel to receive first shipment of Pfizer anti-COVID pills in coming week — report
PM Naftali Bennett speaks to Pfizer CEO to finalize purchase of 100,000 pills shown to reduce risk of hospitalization, death in high-risk groups by 90%
By ToI Staff and Agencies
Stephane Bancel, CEO of Moderna, speaks to the media after Massachusetts Gov. Charlie Baker toured the Moderna facility, on May 12, 2021, in Norwood, Massachusetts. (Nancy Lane/The Boston Herald via AP, Pool)
November 30, 2021, 8:53 am
Moderna CEO predicts existing COVID vaccines less effective against Omicron
Stephane Bancel says there’s ‘no world’ in which protection will prove to be the same against new strain, says he expects a ‘material drop’
By ToI Staff
Pfizer CEO Albert Bourla speaks during a ceremony in Thessaloniki, Greece, on October 12, 2021. (AP Photo/Giannis Papanikos, File)
November 29, 2021, 8:11 pm
Pfizer CEO: We’re working on vaccine for Omicron; our pill will also be effective
Albert Bourla says new shot may be needed if testing shows existing vaccine provides less protection against new coronavirus variant
By AFP
13-year-old Tomer Zarfati receives his second dose of the COVID-19 vaccine at a temporary Clalit health care center in Jerusalem, August 29, 2021. (Yonatan Sindel/Flash90)
November 23, 2021, 10:46 am
Pfizer says COVID-19 vaccine 100% effective in adolescents after 4 months
No serious safety concerns seen in individuals with at least 6 months of follow-up after 2nd dose; pharma giant says data will help support application for full approval
By AFP and ToI Staff
The Pfizer company logo at the drug company's headquarters in New York. (Don EMMERT / AFP)
November 16, 2021, 5:04 pm
Pfizer strikes global licensing deal for antiviral COVID pill
Move could make treatment available to more than half the world’s population, by allowing generic drug companies to produce the pill cheaply in 95 low- and middle-income nations
By Robin MILLARD
Load More
Sign in or Join The Times of Israel Community
Paying ToI Community members are invited to comment on articles
Please use the following structure: example@domain.com
Or Continue with
By joining you agree to the terms and conditions
Register to continue
Or Continue with
Log in to continue
Sign in or Join The Times of Israel Community
Only ToI Community members can comment below articles
Forgot your password? / Send me a login link
Or Continue with
check your email
Check your email
We sent an email to you at .
It has a link that will sign you in.
Join The Times of Israel Community
Commenting is available for paying members of The Times of Israel Community only. Please join our Community to comment and enjoy other Community benefits.
Please use the following structure: example@domain.com
Confirm Mail
Thank you! Now check your email
You are now a member of The Times of Israel Community! We sent you an email with a login link to . Once you're set up, you can start enjoying Community benefits and commenting.
Back to top
Never miss breaking news on Israel
Get notifications to stay updated
You're subscribed
image
Register for free
and continue reading
Registering allows you to manage your newsletters and alerts and helps us improve your experience. It takes just a few seconds.
Already registered? Enter your email to sign in.
Please use the following structure: example@domain.com
Or Continue with
By registering you agree to the terms and conditions. Once registered, you’ll receive our Daily Edition email for free.
Register to continue
Or Continue with
Log in to continue
Sign in or Register
I forgot my password / Send me a sign in link
Or Continue with
check your email
Check your email
We sent an email to you at .
It has a link that will sign you in.